Home/Stocks/Financials

Aberforth Smaller Companies Trust PLC

ASL.L·Financials·Market Cap £1.4b
Rank #235 of 280
Quantitative Model · 280 Stocks Analysed
£18.26
+16.83% YTD
52W: £14.08 - £18.35

Factor Analysis Summary

Editorial assessment generated from Aberforth Smaller Companies Trust PLC's live factor scores and sector positioning.

Based on Strategyland's proprietary 7-factor analysis, Aberforth Smaller Companies Trust PLC (ASL.L) currently holds an overall rank of #235 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.

Key strengths include market trading, where it demonstrates strong market trading characteristics with favourable volume trends and institutional participation; profitability (ROE 6.9%, net margin 83.4%), where it demonstrates strong profitability metrics, ranking in the top quartile for earnings quality and return on capital; and technical (RSI 73.5), where it demonstrates positive technical momentum with price action supporting a constructive trend.

Areas requiring attention include liquidity, where thin trading volumes could increase transaction costs and slippage, as well as asset efficiency, where poor capital efficiency suggests assets may be underutilised or overvalued on the balance sheet.

Within the Financials sector, Aberforth Smaller Companies Trust PLC sits at composite rank #235, trailing the Financials peer average (rank 8). It ranks behind all 6 tracked Financials peers in our model.

Despite its mid-table composite rank of #235, Aberforth Smaller Companies Trust PLC shows selective strength — notably in market trading and profitability — suggesting a stock with identifiable merits alongside clear areas for improvement.

Strongest Factors

  • Market Trading — Rank 1/280 (top quartile)
  • Profitability — Rank 26/280 (top quartile)
  • Technical — Rank 28/280 (top quartile)

Weakest Factors

  • Liquidity — Rank 257/280 (below average)
  • Asset Efficiency — Rank 197/280 (below average)

Score Analysis

Aberforth Smaller Companies Trust PLC is ranked #235 out of 280 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

92/280
Average Score
Liquidity
Weak257/280
Valuation
Good86/280
Profitability
Excellent26/280
Solvency
Excellent46/280
Asset Efficiency
Weak197/280
Mkt Trading
Excellent1/280
Technical
Excellent28/280

1. Liquidity

Score: 257/280

How liquid is ASL and can it meet its short-term obligations?

0/6
liquidity criteria met
–
Quick RatioN/A
Range: N/A
–
Current Ratio0.12x
Range: N/ARank 244/280
–
TTM Operating Cash Flow1.08x
Range: N/ARank 47/280
–
Liquidity Coverage RatioN/A
Range: 100-150
–
Intangible Asset RatioN/A
Range: 10 - 30Rank 193/280
–
Cash-to-Debt Ratio0.07x
Range: N/ARank 213/280

Key Liquidity Metrics

Quick Ratio
N/A
Sector: N/A
Current Ratio
0.12x
Sector: N/A

Overall Liquidity Rank

Rank within universe#257/280
Best (1)Worst (280)

2. Valuation

Score: 86/280

Is ASL undervalued compared to its peers and fair value metrics?

3/7
valuation criteria met
–
FY27e P/EN/A
Range: 8x - 18x
–
FY26e P/EN/A
Range: 8x - 18x
–
FY27e Net Div Yld (%)N/A
Range: 3.0 - 8.0
✓
Div Payout Ratio49.79%
Range: 30 - 55Rank 100/280
–
Current EV/EBITDA13.1x
Range: N/ARank 205/280
✓
Current P/TBV0.90x
Range: 0.8x - 2.0xRank 40/280
✓
Current P/B0.90x
Range: 0.8x - 2.0xRank 49/280

Key Valuation Metrics

TTM P/E
Price-to-Earnings
15.8x
FY26e P/E
Forward estimate
N/A
FY27e P/E
Forward estimate
N/A
Current P/B
Price-to-Book
0.90x
Current P/TBV
Tangible Book Value
0.90x
Current EV/EBITDA
Enterprise Value
13.1x
FY26e EV/EBITDA
Forward estimate
N/A
FY27e EV/EBITDA
Forward estimate
N/A

Dividend

ASL pays a dividend yield of 2.87%.

Current Yield
2.87%
FY27e Net Div Yield
N/A
FY26e Gross DPS
N/A
FY27e Gross DPS
N/A

3. Profitability

Score: 26/280

How profitable is ASL relative to its peers?

0/7
profitability criteria met
✗
TTM Profit Margin83.4%
Range: 15 - 30Rank 51/280
–
T12 FCF Margin0.5%
Range: N/ARank 96/280
–
FY27e RoEN/A
Range: 10 - 16
–
FY26 EPS GrowthN/A
Range: 8 - 15
–
FY27e EPS GrowthN/A
Range: 6 - 12
–
NIMN/A
Range: 1.5 - 3.2
–
Expense RatioN/A
Range: 50 - 65
TTM Profit Margin
83.4%
Current RoCE
6.9%
FY27e RoE
N/A
T12 FCF Margin
0.5%

4. Solvency

Score: 46/280

How strong is ASL's balance sheet and financial position?

0/6
solvency criteria met
✗
Debt/Eqt0.05x
Range: 0.5x - 1.5xRank 41/280
–
Interest Coverage RatioRank 77
Range: N/ARank 77/280
–
Net Leverage RatioN/A
Range: N/A
–
Altman Z-Score (Manufacturing)20.63
Range: N/ARank 40/280
–
Z-Score (Non Manufacturing)Rank 41
Range: N/ARank 41/280
–
CapAdeq Ratio Tier1N/A
Range: 13 - 18

Key Solvency Metrics

Debt/Eqt
0.05x
Net Leverage Ratio
N/A
Interest Coverage
Rank 77
T12 FCF Margin
0.5%

Altman Z-Score

20.63
Safe Zone
01.812.995+

5. Asset Efficiency

Score: 197/280

How efficiently does ASL deploy its assets and intellectual capital?

0/5
asset efficiency criteria met
–
Efficiency RatioN/A
Range: 50 - 70
–
TTM Asset Turnover Ratio0.07x
Range: N/ARank 232/280
–
TTM CAPEX/SalesN/A
Range: 1 - 3
–
Working Capital TurnoverN/A
Range: N/A
–
R&D/Sales FY27eN/A
Range: N/A

Overall Asset Efficiency Rank

Rank within sector peers#197/280
Best (1)Worst (280)

6. Market Trading

Score: 1/280

How liquid and actively traded is ASL?

1/2
market trading criteria met
–
Intraday Sentiment (%)N/A
Range: 40 - 75
–
10D-Avg v/s 3M-Avg Vol82%
Range: N/ARank 50/280
✓
Avg Directional Index 30D31.0
Range: 012 - 45Rank 25/280
–
Parabolic SAR1812.19
Range: N/ARank 60/280
–
Stock Rating RankN/A
Range: N/A
Market Cap
£1,381,179,187
Enterprise Value
£1,465,985,187

Trading Volume

7. Technical

Score: 28/280

What do the technical indicators say about ASL?

0/5
technical criteria met
–
CMP v/s 52-WH-0.5%
£18.35£14.08
-0.5%CMP: £18.26
Range: N/ARank 6/280
–
CMP v/s 52-WL29.7%
£18.35£14.08
+29.7%CMP: £18.26
Range: N/ARank 160/280
–
RSI 14D73.5
073.5 - Overbought100
Range: N/ARank 25/280
–
MA50 - MA200Bullish
£16.44+1.09£17.54
Range: N/ARank 43/280
–
MACD Rank4.24
Golden Cross
MACD: 4.24
Range: N/ARank 100/280

RSI (14 Day)

73.5
Overbought
0 (Oversold)50100 (Overbought)

Moving Averages

50 SMA£17.54
200 SMA£16.44
SignalGolden Cross (Bullish)
MACD4.24

Risk Metrics

Beta
N/A
3-Yr Std Dev
N/A
5-Yr Std Dev
N/A

Peer Comparison

How does ASL compare to other Financials stocks?

Overall Rank Comparison

Factor Score Comparison

StockRankLiquidityValuationProfitabilitySolvencyMkt TradingTechnical
ASL#235257862646128
MUT.L#3128382456278
RTW.L#51167914569229
BPCR.L#71633456911276
RCP.L#9179262259132
AGT.L#111085755729079
TBCG.L#1429553825712918
Sponsored
Healthcare Discovery Monitor
Live
Healthcare Discovery Monitor
Healthcare Discovery Monitorby StrategyLand

Catch Healthcare Events Before the Market Moves

SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.

10+
Sources
4
Markets
12h
Cycle
50+
Keywords
USUKCNEU
Launch Monitor

Methodology Note

The analysis presented for Aberforth Smaller Companies Trust PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.

Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.

This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.

Note: The information provided is not intended as an offer or solicitation for the purchase or sale of any financial instruments but for investor relations purposes only. The aforementioned securities were offered to the public and currently trade on the secondary market at the exchange mentioned above. It is recommended that investors considering investing in any of these notes consult an approved MiFID Financial Advisor prior to investing.